Terumo (OTCMKTS:TRUMY) Shares Gap Down – Time to Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $13.80, but opened at $13.39. Terumo shares last traded at $13.3770, with a volume of 24,874 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research raised Terumo to a “hold” rating in a research note on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Terumo Stock Performance

The company has a quick ratio of 0.97, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $13.85 and a 200 day moving average price of $13.59. The stock has a market cap of $19.77 billion, a P/E ratio of 21.98 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. As a group, sell-side analysts expect that Terumo Corp. will post 0.7 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.